Literature DB >> 19088741

Dopamine release in the human striatum: motor and cognitive tasks revisited.

Julia M Lappin1, Suzanne J Reeves, Mitul A Mehta, Alice Egerton, Mark Coulson, Paul M Grasby.   

Abstract

Striatal dopamine (DA) release has been shown during behavioural tasks, but the relative contribution of motor, reward, and cognitive components is unclear. Dopamine release was quantified using [(11)C]-raclopride in two studies using a triple-scan approach, comprising active task, motor control, and rest. In the first, bolus radiotracer was delivered during a sequential motor learning paradigm; in the second, a spatial planning task, bolus plus constant infusion was applied. [(11)C]-raclopride binding potentials (BP(ND)s) in striatal functional subdivisions were compared across conditions. [(11)C]-raclopride BP(ND) was significantly reduced in active task compared with rest in both the sensorimotor and associative striatum in both studies, because of differences between rest and motor control conditions. In both regions, the motor control BP(ND) fell between the rest and active task in the planning study, but the difference between motor control and active task conditions was not significant. No such changes were observed in the limbic striatum. Using rigorous methodology, this study validates earlier evidence that striatal DA release occurs during behavioural challenges. Increased DA release during movement was reliably detected in the sensorimotor and associative striatum, supporting use of the functional subdivision model in humans. No additional DA release was observed specific to the cognitive component of either task.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088741     DOI: 10.1038/jcbfm.2008.146

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  21 in total

1.  The response to rapid infusion of fentanyl in the human brain measured using pulsed arterial spin labelling.

Authors:  Fernando O Zelaya; Evangelos Zois; Christopher Muller-Pollard; David J Lythgoe; Sarah Lee; Caroline Andrews; Trevor Smart; Patricia Conrod; William Vennart; Steven C R Williams; Mitul A Mehta; Laurence J Reed
Journal:  MAGMA       Date:  2011-11-24       Impact factor: 2.310

2.  Imaging human reward processing with positron emission tomography and functional magnetic resonance imaging.

Authors:  Nina B L Urban; Mark Slifstein; Shashwath Meda; Xiaoyan Xu; Rawad Ayoub; Olga Medina; Godfrey D Pearlson; John H Krystal; Anissa Abi-Dargham
Journal:  Psychopharmacology (Berl)       Date:  2011-11-04       Impact factor: 4.530

3.  Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis.

Authors:  Teresa M Karrer; Anika K Josef; Rui Mata; Evan D Morris; Gregory R Samanez-Larkin
Journal:  Neurobiol Aging       Date:  2017-05-12       Impact factor: 4.673

4.  Impaired prefrontal-basal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia.

Authors:  Jong H Yoon; Michael J Minzenberg; Sherief Raouf; Mark D'Esposito; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2013-01-03       Impact factor: 13.382

5.  Lateralization and gender differences in the dopaminergic response to unpredictable reward in the human ventral striatum.

Authors:  Chantal Martin-Soelch; Joanna Szczepanik; Allison Nugent; Krystle Barhaghi; Denise Rallis; Peter Herscovitch; Richard E Carson; Wayne C Drevets
Journal:  Eur J Neurosci       Date:  2011-04-01       Impact factor: 3.386

6.  Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.

Authors:  Ivonne Suridjan; Pablo Rusjan; Jean Addington; Alan A Wilson; Sylvain Houle; Romina Mizrahi
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

Review 7.  The role of neuroplasticity in dopaminergic therapy for Parkinson disease.

Authors:  Xiaoxi Zhuang; Pietro Mazzoni; Un Jung Kang
Journal:  Nat Rev Neurol       Date:  2013-04-16       Impact factor: 42.937

8.  Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study.

Authors:  Alice Egerton; John P Shotbolt; Paul R A Stokes; Ella Hirani; Rabia Ahmad; Julia M Lappin; Suzanne J Reeves; Mitul A Mehta; Oliver D Howes; Paul M Grasby
Journal:  Neuroimage       Date:  2009-12-05       Impact factor: 6.556

Review 9.  Does the difference between physically active and couch potato lie in the dopamine system?

Authors:  Amy M Knab; J Timothy Lightfoot
Journal:  Int J Biol Sci       Date:  2010-03-09       Impact factor: 6.580

Review 10.  Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD.

Authors:  Benjamin D Greenberg; Scott L Rauch; Suzanne N Haber
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.